Digital Therapeutics

Better Therapeutics plans to go public through SPAC merger 

  • by

Digital health startup Better Therapeutics plans to go public through a SPAC merger that would value it at $187 million. The company is currently running a pivotal study to see if its app-based program could be used as a treatment for type 2 diabetes. 

Gamification for patient care, medical education, and virtual engagement

  • by

“Gamification” – adding game-like elements into non-game or real-world settings – has become a popular concept in the pharmaceutical, healthcare, and event industries, especially as virtual engagement becomes more common during COVID-19. However, it is proving more than a mere buzzword. With diverse applications and… Read More »Gamification for patient care, medical education, and virtual engagement

Wellstar Invests $10M to Become First Sharecare-Enabled Health System

  • by

Wellstar Health System, one of Georgia’s largest and most integrated healthcare systems, and Sharecare, the digital health company that helps people manage all their health in one place, announced a strategic partnership to collaborate on unique, market-leading innovations in personalized care delivery, population health, and… Read More »Wellstar Invests $10M to Become First Sharecare-Enabled Health System

Italy eyes Digital Therapeutics

  • by

The recommendations for the Country’s pathway towards DTx are captured in the White Paper “Digital Therapeutics, an Opportunity for Italy” The official journal of the Smith Kline Foundation, Tendenze Nuove, published the White Paper “Digital Therapeutics, an Opportunity for Italy” on 13 January 2021. The… Read More »Italy eyes Digital Therapeutics

Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health – M&A

  • by

What You Should Know: – DTx and Patient Support leaders, Amalgam Rx, Inc., announce the acquisition of Avhana Health, a privately-held clinical decision support (CDS) company. Amalgam Rx, Inc., a Wilmington, DE-based Digital Therapeutics and Patient Support company, announces the acquisition of Avhana Health, a… Read More »Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health – M&A

Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population

  • by

What You Should Know: –  Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population. – Vida’s diabetes management program achieves lasting results for participants. Because chronic conditions like diabetes, obesity, and hypertension often occur simultaneously,… Read More »Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population

Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health

  • by

What You Should Know: – Cerner Corporation today announced with Xealth new centralized digital ordering and monitoring for health systems, starting with Banner Health, to foster digital innovation. – Health systems can prescribe digital therapeutics, smartphones, and internet apps directly within the EHR to address… Read More »Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health

Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms

  • by

What You Should Know: – Lightspeed Venture Partners, the VC behind Nest and GrubHub, is leading a $10 million round for Freespira, an FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks and PTSD symptoms by training users to normalize respiratory irregularities. –… Read More »Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms

UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications

  • by

What You Should Know: – UCB has selected Medisafe to develop branded digital drug companions for antiepileptic medications, marking the company’s official entry into the digital therapeutics space. – The initial collaboration will primarily be focused on their antiepileptic medications, but they are exploring its… Read More »UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications

Frontiers Health 2020 day two

  • by

It’s day two of digital health innovation conference Frontiers Health, which will be mainly held online because of the COVID-19 pandemic. This year Frontiers will be a global Hybrid conference. In line with the “new normal” situation, the format of the 2020 edition will be hybrid combining online global streaming together with offline events and… Read More »Frontiers Health 2020 day two

Frontiers Health 2020 day one

  • by

Digital health innovation conference Frontiers Health kicks off its 2020 edition this week, although the majority of the conference will be held online because of the COVID-19 pandemic. This year, Frontiers will be a global Hybrid conference. In line with the “new normal” situation, the… Read More »Frontiers Health 2020 day one

FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

  • by

What You Should Know: – FDA awards AppliedVR Breakthrough Device designation for treating treatment-resistant fibromyalgia and chronic intractable lower back pain – AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR, a pioneer advancing… Read More »FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

AI drug-discovery firm lands first partnership

  • by

The deal with Roche subsidiary Genentech is likely not the last for Genesis Therapeutics, which is based on AI research undertaken at Stanford. Such partnerships are potentially lucrative for drug-discovery startups.

Digital Therapeutics: Key Concepts and Regulations to Tackle COVID-19 Pandemic

  • by

Digital therapeutics are clinically validated applications / software / online programs that have demonstrated the capability to facilitate positive outcomes when used in the prevention / treatment / management of diseases / clinical conditions. These therapeutics are designed to engage patients in personalized treatment or… Read More »Digital Therapeutics: Key Concepts and Regulations to Tackle COVID-19 Pandemic

Digital Therapeutics Company DarioHealth Raises $28M to Expand Market Share

  • by

What You Should Know: DarioHealth raises $28M in institutional financing intended to finance growth of their digital therapeutics B2B market share with employers, health insurance plans, and healthcare providers. The company sold 2,969,266 shares of common stock and, to certain investors in lieu thereof, pre-funded… Read More »Digital Therapeutics Company DarioHealth Raises $28M to Expand Market Share

Biocon Collaborates with Voluntis on Digital Therapeutics for Insulins

  • by

Shots: The two companies collaborated to develop and distribute innovative digital therapeutics supporting people with diabetes on biologics therapy. The collaboration allows Biocon to offer Insulia to T2D patients across several markets globally Biocon aspires to reimagine the patient ecosystem by developing a technology-dependent operating… Read More »Biocon Collaborates with Voluntis on Digital Therapeutics for Insulins

DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland

  • by

What You Should Know: – Dario Health enters strategic partnership with Williams Medical marking its expansion into the UK remote patient monitoring market across the UK and Ireland. – Williams Medical is the leading provider of medical goods and services to primary care in the… Read More »DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland

Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics

  • by

What You Should Know: – Repurpose.AI, has partnered with Scripps Research to discover drug candidates that may be repurposed to treat COVID-19.  – The partnership will leverage Repurpose.AI’s ActivPred AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic digital chemistry engine, to discover… Read More »Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics